Nathan Kerr

Abstract To compare canaloplasty and trabecular micro-bypass surgery outcomes in primary open-angle glaucoma (POAG). Ambispective study using data from the International Glaucoma Surgery Registry (IGSR) to evaluate mild-to-moderate POAG patients who underwent iTrack ab-interno canaloplasty (Nova Eye Medical, USA) (prospective cohort) or iStent trabecular micro-bypass implantation (Glaukos, USA) (retrospective cohort), with or without concomitant phacoemulsification, and ≥12 months of follow-up.

While much of the initial focus has been on stent-based procedures, there is increasing attention on canaloplasty, a procedure where a microcatheter is used to dilate and flush out the eye’s natural drainage channels, in effect like angioplasty for the eye. This tissue-sparing and implant-free MIGS procedure targets the entire 360° of the outflow pathway to treat all points of outflow resistance and re-establish the function of the natural conventional outflow pathway.

1T hour with Assessment – Optometry Australia IoE Quality Assurance | TBC in New Zealand The introduction of minimally invasive glaucoma surgery, commonly called MIGS, has triggered a paradigm shift in the way glaucoma is treated. Traditional surgical options, while effective and powerful, have typically been a ‘one-size-fits-all’ approach. With potentially sight-threatening complications and a prolonged recovery, they were often reserved for late in the disease process…Read and take test.